Company Overview
Snapshot
Founded in January 2006 by Lior Berkner, Cardicell operates with 1–10 employees. The company is currently in a Pre-Funding stage, with its last known event being a closing event in November 2016.
Business overview
Cardicell is a Health Tech & Life Sciences company focused on developing self-care medical devices for cardiac tele-medicine. Its core product is a portable device designed for the preliminary diagnosis of chest pains, enabling prompt analysis of heart attacks. This technology utilizes a signal-acquisition method for wireless detection of cardiac abnormalities, making it user-friendly for the general population without requiring prior medical knowledge. The company operates in the medical devices sector, specifically diagnostics devices, targeting healthcare providers.
Log in to access full profile ›Company Intelligence Q&A
- What is Cardicell's primary focus?
- Cardicell is focused on developing self-care medical devices within the cardiac tele-medicine field for detecting life-threatening heart conditions.
- Who founded Cardicell?
- Cardicell was founded by Lior Berkner in January 2006.
- What is the core technology behind Cardicell's product?
- Cardicell's core technology involves a signal-acquisition method that enables wireless detection of cardiac abnormalities, integrated with a user-friendly interface for instant heart attack detection.
- What is the current status of Cardicell?
- Cardicell is currently in a Non Active status as of November 2016, and is in a Pre-Funding stage.
- What is the intended use of Cardicell's current product?
- Cardicell's current product is designed to allow the general population to perform preliminary diagnosis of chest pains, facilitating prompt analysis of potential heart attacks without requiring prior medical knowledge.